Therapeutic management of brain metastasis

This review focuses on the management of brain metastases. The four main modes of therapy are discussed: whole brain radiation therapy (WBRT), surgery, radiosurgery, and chemotherapy. Young patients with limited extracranial disease may benefit from surgical resection of a single brain metastasis, and from radiosurgery (or stereotactic radiotherapy) if two to four brain metastases are present. Whether WBRT after surgery or radiosurgery is beneficial is uncertain. Therefore, two approaches can be justified in patients with a good prognosis: WBRT after surgery or radiosurgery, or alternatively, observation with MRI follow-up after surgery or radiosurgery. A hyperfractionated radiation scheme is then to be preferred to limit late toxicity of WBRT. Patients with extensive extracranial tumour activity or impaired quality of life may benefit from radiosurgery (one to four brain metastases), or from shorter WBRT schedules. We propose a decision tree on the various ways to treat brain metastasis.

[1]  H. Choy,et al.  Prophylactic cranial irradiation in small cell lung cancer: rationale, results, and recommendations. , 1997, Seminars in oncology.

[2]  M. Mehta,et al.  A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. , 1996, International journal of radiation oncology, biology, physics.

[3]  G. Krol,et al.  Distribution of brain metastases. , 1988, Archives of neurology.

[4]  G. Duncan,et al.  A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis , 1996, Cancer.

[5]  A. Ardizzoni,et al.  The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer. , 2001, Critical reviews in oncology/hematology.

[6]  A. Hauschild,et al.  A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma , 2003, Melanoma research.

[7]  A. Sartore-Bianchi,et al.  Controversies in the management of brain metastases: the role of chemotherapy. , 2001, Forum.

[8]  K. Lillehei,et al.  Multiple brain metastases are associated with poor survival in patients treated with surgery and radiotherapy. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  T. Solberg,et al.  Prospective Study of Stereotactic Radiosurgery Without Whole Brain Radiotherapy in Patients with Four or Less Brain Metastases: Incidence of Intracranial Progression and Salvage Radiotherapy , 2004, Journal of Neuro-Oncology.

[10]  W R Markesbery,et al.  Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. , 1998, JAMA.

[11]  E. Shaw,et al.  RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Mehta,et al.  Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. , 2001, International journal of radiation oncology, biology, physics.

[13]  D. Kondziolka,et al.  Brain Metastases Treated with Radiosurgery Alone: An Alternative to Whole Brain Radiotherapy? , 2003, Neurosurgery.

[14]  T. Miyazawa,et al.  Gefitinib as a first line of therapy in non-small cell lung cancer with brain metastases. , 2004, Internal medicine.

[15]  C. Ostertag,et al.  Radiosurgery followed by planned observation in patients with one to three brain metastases. , 2003, Neurosurgery.

[16]  L. Abrey,et al.  Temozolomide for treating brain metastases. , 2001, Seminars in oncology.

[17]  E. Winer,et al.  Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma , 2003, Cancer.

[18]  J. Holland,et al.  Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. Schiller,et al.  Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer , 2001, Oncology.

[20]  N. Viñolas,et al.  Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. , 2005, International journal of radiation oncology, biology, physics.

[21]  D. Antonadou,et al.  Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  A. Young,et al.  Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. , 2002, International journal of radiation oncology, biology, physics.

[23]  G. Giaccone,et al.  Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965). , 2003, European journal of cancer.

[24]  R. Gelber,et al.  The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. , 1980, International journal of radiation oncology, biology, physics.

[25]  M. Mehta,et al.  Stereotactic radiosurgery for brain metastases. , 1999, Oncology.

[26]  A. Young,et al.  Recursive Partitioning Analysis Classifications I and II: Applicability Evaluated in a Randomized Trial for Resected Single Brain Metastases , 2004, American journal of clinical oncology.

[27]  J P Pignon,et al.  Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. , 1999, The New England journal of medicine.

[28]  R. Arriagada,et al.  Prophylactic cranial irradiation in small cell lung cancer. , 2003, Seminars in oncology.

[29]  J. Dunn,et al.  Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases. , 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).

[30]  K. Kiura,et al.  Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer. , 2004, Lung cancer.

[31]  A. Chiappori,et al.  Treatment of relapsed small-cell lung cancer--a focus on the evolving role of topotecan. , 2003, Lung cancer.

[32]  A. Goldhirsch,et al.  High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[33]  S. Leung,et al.  Prolonged survival in a subgroup of patients with brain metastases treated by gamma knife surgery. , 2005, Journal of neurosurgery.

[34]  T. Phillips,et al.  A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). , 1991, International journal of radiation oncology, biology, physics.

[35]  R. Sawaya,et al.  Surgical treatment of multiple brain metastases. , 1993, Journal of neurosurgery.

[36]  L D Lunsford,et al.  A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. , 1994, International journal of radiation oncology, biology, physics.

[37]  W. Curran,et al.  Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  L. Deangelis,et al.  Radiation‐induced dementia in patients cured of brain metastases , 1989, Neurology.

[39]  J. Raizer,et al.  A Phase II Trial of Temozolomide for Patients with Recurrent or Progressive Brain Metastases , 2004, Journal of Neuro-Oncology.

[40]  C. Ostertag,et al.  Long-term survival in patients with brain metastases , 2002, Journal of Cancer Research and Clinical Oncology.

[41]  Primary chemotherapy of brain metastasis in small-cell lung cancer. , 1989 .

[42]  W. Regine,et al.  Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy. , 2002, International journal of radiation oncology, biology, physics.

[43]  L Gaspar,et al.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. , 1997, International journal of radiation oncology, biology, physics.

[44]  W Curran,et al.  Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. , 2000, International journal of radiation oncology, biology, physics.

[45]  A. Bamias,et al.  Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study , 2004, Journal of Neuro-Oncology.

[46]  Y Maruyama,et al.  A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.

[47]  J. Verdebout,et al.  Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis , 2001, BMC Cancer.

[48]  J. Adler,et al.  Linear accelerator-based stereotaxic radiosurgery for brain metastases:the influence of number of lesions on survival. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  Maria Werner-Wasik,et al.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial , 2004, The Lancet.

[50]  M. Bent The role of chemotherapy in brain metastases , 2003 .

[51]  J. O'fallon,et al.  A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. , 2003, International journal of radiation oncology, biology, physics.

[52]  Bruno Vanderlinden,et al.  Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. , 2004, International journal of radiation oncology, biology, physics.

[53]  G. Barnett,et al.  Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases. , 2000, International journal of radiation oncology, biology, physics.

[54]  A. Carretta,et al.  Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment , 2002, Cancer.

[55]  P. Levendag,et al.  Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. , 1999, International journal of radiation oncology, biology, physics.

[56]  T. Shuto,et al.  Repeated gamma knife radiosurgery for multiple metastatic brain tumours , 2004, Acta Neurochirurgica.

[57]  J. Pujol,et al.  Concomitant brain radiotherapy and vinorelbine-ifosfamide-cisplatin chemotherapy in brain metastases of non-small cell lung cancer. , 1999, Lung cancer.

[58]  E. Lower,et al.  Increased rate of brain metastasis with trastuzumab therapy not associated with impaired survival. , 2003, Clinical breast cancer.

[59]  T. Phillips,et al.  Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05. , 1995, International journal of radiation oncology, biology, physics.

[60]  Jung-Il Lee,et al.  Gamma knife surgery for brain metastases in patients harboring four or more lesions: survival and prognostic factors. , 2005, Journal of neurosurgery.

[61]  T Sahmoud,et al.  Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  R. Müller,et al.  Linac Radiosurgery Versus Whole Brain Radiotherapy for Brain Metastases , 2004, Strahlentherapie und Onkologie.

[63]  F. Lohr,et al.  Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  M. Ranson,et al.  Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  Front‐line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma , 1999 .

[66]  K. Possinger,et al.  Chemotherapy for Breast Cancer Brain Metastases , 2002, Oncology Research and Treatment.

[67]  P. Kosmidis,et al.  Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[68]  Ronald Brand,et al.  Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery , 1993, Annals of neurology.

[69]  K. Misulis,et al.  Cerebellar metastases: diagnostic and management considerations. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  J. Sosman,et al.  Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group , 2002, Journal of Cancer Research and Clinical Oncology.

[71]  D. Wajsbrot,et al.  Radiosurgery for brain metastases: a score index for predicting prognosis. , 2000, International journal of radiation oncology, biology, physics.

[72]  H. Eich,et al.  Phase I/II Trial of Simultaneous Whole-Brain Irradiation and Dose-Escalating Topotecan for Brain Metastases , 2005, Strahlentherapie und Onkologie.

[73]  E. Thiel,et al.  Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation. a multicentre phase II study. , 2002, European journal of cancer.

[74]  Michael I. Seider,et al.  A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. , 1997, International journal of radiation oncology, biology, physics.

[75]  M. Mehta,et al.  A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. , 2002, International journal of radiation oncology, biology, physics.